Ingredient in red chili pepper has cancer-fighting properties

	Tweet

A new study suggests that an ingredient in red chili pepper has cancer-fighting properties that prevent or slow the growth of pancreatic cancer tumors implanted in mice.

The study found that capsaicin, the “hot” ingredient in red chili pepper, caused pancreatic cancer cells to die through a process called apoptosis. Apoptosis, the body’s normal method of disposing of damaged, unwanted or unneeded cells, is often defective in cancer cells, causing them to continue to thrive.

“In our study, we discovered that capsaicin fed orally to mice with human pancreatic tumors was an extremely effective inhibitor of the cancer process, inducing apoptosis in cancer cells,” said Sanjay K. Srivastava, Ph.D., lead investigator and assistant professor, department of pharmacology, University of Pittsburgh School of Medicine. “Capsaicin triggered the cancerous cells to die off and significantly reduced the size of the tumors.”

Dr. Srivastava and colleagues fed mice grafted with human pancreatic tumors different amounts of capsaicin for five days per week or three days per week according to their weight, then compared tumor size and levels of apoptotic proteins in the tumors to a control group of mice that received normal saline only. They found that the mice that received capsaicin had increased levels of proteins associated with apoptosis and significantly smaller tumor sizes than the control group. Tumors treated with capsaicin were half the size of tumors in non-treated mice. Further testing revealed that capsaicin disrupted the mitochondrial function, which resulted in the release of several apoptotic proteins, but that it did not negatively affect normal pancreatic cells.

“Our results demonstrate that capsaicin is a potent anticancer agent, induces apoptosis in cancer cells and produces no significant damage to normal pancreatic cells, indicating its potential use as a novel agent for the prevention and treatment of pancreatic cancer,” said Dr. Srivastava.

Pancreatic cancer is the fifth-leading cause of cancer death in the United States and is one of the most aggressive cancers, with an extremely poor prognosis.

http://ww.upmc.com

RELATED STORIES:
Possible Genetic Link to Pancreatic Cancer   Rare pancreatic cancer patients may live longer when treated with radiation therapy   Gene Discovered by Researchers Tied to Pancreatic Cancer   New treatment combination safe for pancreatic cancer patients   Tests may detect mesothelioma, pancreatic cancer   Gefitinib may have chemopreventive benefits in pancreatic cancer   No support for routine pancreatic cancer screening   Pancreatic cancer and ecoendoscop   Radiation Before Surgery Improves Pancreatic Cancer Outcomes   Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy   Alcohol Consumption May Increase Pancreatic Cancer Risk   Gene therapy tested in pancreatic cancer studies   Link Found Between Periodontal Disease and Pancreatic Cancer   Americans mixed on adequacy of cancer screenings: poll   Some support for pancreatic cancer screening   First Use of Innovative “IRE” on Pancreatic Tumor   Sugary foods linked to pancreatic cancer risk   Malaria drug slows pancreatic cancer growth in mouse models   Micro Molecules Can Identify Pancreatic Cancer   Age important in hereditary pancreatic cancer risk   Pancreatic Neuroendocrine Cancer   Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]